Free radicals and theophylline neurotoxicity : an experimental study.
Free radicals play a crucial role in health and disease and both reactive oxygen species (ROS) and reactive nitrogen species (RNS) have been implicated in CNS effects like excitotoxicity. Theophylline, a re-emerging drug for the treatment of obstructive airway disease, has a narrow therapeutic index which precludes its safe use. The present study evaluated the possible involvement of free radicals in theophylline induced seizures in mice. Aminophylline (100-250 mg/kg) consistently induced seizures and post-ictal mortality, and conventional anticonvulsants and adenosine agonists were ineffective in antagonizing them. Further, phosphodiesterase inhibitors, per se, also did not show any significant seizurogenic potential. Pretreatments with antioxidants, ascorbic acid, alpha-tocopherol and melatonin, all dose dependently reduced seizure incidence and mortality after aminophylline, whereas, antioxidant depletion potentiated such excitotoxicity. Pretreatments with the NO synthase inhibitors, L-NAME and 7-NI blocked aminophylline seizures, whereas, the NO mimetics, L-arginine and glyceryl trinitrate, tended to potentiate this phenomenon. Sub-effective doses of aminophylline (100 mg/kg) also induced seizures when combined with subthreshold intensity of electroshock, and such seizures were similarly antagonized by the antioxidants and NO synthase inhibitors. Biochemical assay of brain homogenates showed that aminophylline seizures were associated with enhancements in brain MDA and NOx (NO metabolites) levels, whereas, SOD activity was reduced, and these changes were attenuated after melatonin and L-NAME pretreatments. The pharmacological and biochemical data are strongly suggestive of the involvement of both ROS and RNS during theophylline-induced seizures.
Gulati
K
K
Department of Pharmacology and Clinical Research Centre, Vallabhbhai Patel Chest Institute, University Of Delhi, Delhi, India.
Ray
A
A
Vijayan
V K
VK
D000628:Aminophylline / Q000633:toxicity; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001120:Arginine / Q000494:pharmacology; D001205:Ascorbic Acid / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005609:Free Radicals / Q000378:metabolism*; D008297:Male; D008550:Melatonin / Q000494:pharmacology; D051379:Mice; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009422:Nervous System Diseases / Q000139:chemically induced / Q000378:metabolism* / Q000517:prevention & control; D005996:Nitroglycerin / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D026361:Reactive Nitrogen Species / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D012640:Seizures / Q000139:chemically induced / Q000378:metabolism* / Q000517:prevention & control; D013482:Superoxide Dismutase / Q000378:metabolism; D013806:Theophylline / Q000633:toxicity*; D024502:alpha-Tocopherol / Q000494:pharmacology
D000975:Antioxidants; D005609:Free Radicals; D010726:Phosphodiesterase Inhibitors; D026361:Reactive Nitrogen Species; D017382:Reactive Oxygen Species; D000628:Aminophylline; D001120:Arginine; D013806:Theophylline; D013482:Superoxide Dismutase; D005996:Nitroglycerin; D024502:alpha-Tocopherol; D008550:Melatonin; D001205:Ascorbic Acid; D019331:NG-Nitroarginine Methyl Ester